跳至主要内容
临床试验/IRCT20160713028901N5
IRCT20160713028901N5招募中4 期

Effect of increasing the duration of Colistin infusion on nephrotoxicity

Esfahan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 50 years(—)
性别
All

入选标准

  • Age 18 to 50 years
  • Receiving colistin at a dose of 4.5 million units every 12 hours (or an equivalent dose according to the patient's kidney function)
  • Creatinine clearance above 50 ml/min at the beginning of the study
  • No history of acute kidney injury (based on history and medical history)
  • Failure to receive other nephrotoxic drugs such as aminoglycosides, amphotericin B, cyclosporine, tacrolimus, furosemide and NSAIDs
  • Not receiving other antioxidant supplements such as vitamins C and E

排除标准

  • Recent use of colistin in the last 7 days
  • Using colistin for less than 3 days
  • Dialysis before starting treatment

研究者

相似试验